Study shows microRNA-based diagnostic identifies squamous lung cancer with 96 percent sensitivity

Dr. Harvey Pass of the NYU Cancer Institute at NYU Langone Medical Center is one of the authors of a research study published in the Journal of Clinical Oncology which shows for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96% sensitivity.

Read the whole article on Physorg

More from Physorg